The differential effects of EPA and DHA on cardiovascular risk factors.
about
Nutraceuticals and Bioactive Components from Fish for Dyslipidemia and Cardiovascular Risk ReductionDocosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?Marine omega-3 phospholipids: metabolism and biological activities.Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive updateKrill products: an overview of animal studiesDHA-containing oilseed: a timely solution for the sustainability issues surrounding fish oil sources of the health-benefitting long-chain omega-3 oilsAn overview: biomolecules from microalgae for animal feed and aquaculture.Algae as nutritional and functional food sources: revisiting our understandingA randomized clinical trial to determine the efficacy of manufacturers' recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction.Plasma phospholipid EPA and DHA are divergently associated with overall mortality in newly diagnosed diabetic patients: results from a follow-up of the Nord-Trøndelag Health (HUNT) Study, Norway.Impact of DHA on metabolic diseases from womb to tomb.Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acidsDietary omega-3 polyunsaturated fatty acids alter the fatty acid composition of hepatic and plasma bioactive lipids in C57BL/6 mice: a lipidomic approach.Differential regulation of hepatic transcription factors in the Wistar rat offspring born to dams fed folic acid, vitamin B12 deficient diets and supplemented with omega-3 fatty acids.Effect of omega-3 polyunsaturated fatty acids on the cytoskeleton: an open-label intervention study.Fish Oil Accelerates Diet-Induced Entrainment of the Mouse Peripheral Clock via GPR120.T cell immunity and cardiovascular metabolic disorders: does metabolism fuel inflammation?The association of cardiovascular risk factors with saturated fatty acids and fatty acid desaturase indices in erythrocyte in middle-aged Korean adultsDifferent gene expression profiles in normo- and dyslipidemic men after fish oil supplementation: results from a randomized controlled trial.Omega-3 fatty acid supplementation and cardiovascular disease.Polymorphisms in FADS1 and FADS2 alter plasma fatty acids and desaturase levels in type 2 diabetic patients with coronary artery disease.Docosahexaenoic acid-supplementation prior to fasting prevents muscle atrophy in mice.An eicosanoid-centric view of atherothrombotic risk factorsHigh-fat fish oil diet prevents hypothalamic inflammatory profile in ratsAssociation of total marine fatty acids, eicosapentaenoic and docosahexaenoic acids, with aortic stiffness in Koreans, whites, and Japanese Americans.Docosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: a randomized controlled trial in young adultsDiet Quality of Overweight and Obese Adults with Intellectual and Developmental Disabilities as Measured by the Healthy Eating Index-2005.Habitual diets rich in dark-green vegetables are associated with an increased response to ω-3 fatty acid supplementation in Americans of African ancestryDHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity.Similarities and differences between the effects of EPA and DHA on markers of atherosclerosis in human subjects.Omega 3 polyunsaturated fatty acids and body weight.Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?The role of marine n-3 fatty acids in improving cardiovascular health: a review.Fish oil omega-3 fatty acids and cardio-metabolic health, alone or with statins.Does omega-3 fatty acid supplementation enhance neural efficiency? A review of the literature.The future for long chain n-3 PUFA in the prevention of coronary heart disease: do we need to target non-fish-eaters?Technological trends and market perspectives for production of microbial oils rich in omega-3.Changes in relative and absolute concentrations of plasma phospholipid fatty acids observed in a randomized trial of Omega-3 fatty acids supplementation in Uganda.Reciprocal modulation of surface expression of annexin A2 in a human umbilical vein endothelial cell-derived cell line by eicosapentaenoic acid and docosahexaenoic acid.Omega-3 polyunsaturated fatty acids reduce vascular endothelial growth factor production and suppress endothelial wound repair.
P2860
Q26747475-8206E51F-EBA2-43DA-9635-004D53E04161Q26797346-CAC7852D-7305-4E90-8899-CBB5946269CFQ27690878-1C79FA2B-03C1-494C-A5BA-AFB75E78C0A2Q28080477-8CF98C0B-1CF8-4584-B5CC-F63E6D9F148FQ28081951-4DCF90CB-AE8E-4791-91FA-B41F4DDD7C09Q28658910-F2C73C81-3F24-4ABC-BF64-B77F6B4C3098Q30388774-26F67F93-E7C1-4DAD-B94E-55283466058BQ30844837-46A4EB3B-B8BE-48AF-911E-CDF1391A713DQ33858896-CBC21EC2-D314-478C-8FC7-69C9442BC021Q34126216-0FFD1A73-A681-452E-A9FC-3B418082FA75Q34780650-79E19C0F-D386-43DF-B340-3B6C2443D295Q35034713-6BA1FDAC-8293-4AA0-83A0-CFD9B39F3787Q35054156-AA876D88-821A-4C41-9A2C-F7DE849A6C73Q35108849-0274BA8D-881B-4C79-8A7A-2CD273003842Q35601152-7D91FD6B-7AAB-443B-AE40-3EDDC27221A0Q35687964-02C17594-FBEF-4131-9DE4-9FB71E5840DAQ36057159-57326885-0DDD-411D-B747-3E022AF6A306Q36203291-DC9FDE4E-187F-458B-AD5E-459066216690Q36356227-A2D80DA5-5DE9-40ED-B6A8-1A2468975AD8Q36387184-6FB51890-09B3-4C10-AFC5-A7F7E822C252Q36714299-BFDE0B5D-4909-49B6-9453-9B409FAF9741Q36892782-C007D10D-9078-41EA-97F1-BF4B6D35A612Q36952174-053FF970-D4D9-4936-9ABC-FA903B0AEAB7Q37156559-C8EFFF97-A0D3-4204-81A7-FCEE331C7AAFQ37215007-37AAEC74-6FEC-405A-98C1-176BB8233ACDQ37310534-AE32F6C3-335E-454B-95CE-E8D3785D3C1DQ37359543-B48632B0-7C65-4B4F-8BB1-1D8DCF3F4F36Q37513348-83C1F5BC-FBE8-41E6-AF54-456760850CC2Q37671776-A963AB4D-648C-473D-8CED-8A1B72E20F3FQ37988638-4B7F839C-32F4-4F1A-A2BE-13B4D110CF3BQ38010550-30D918DF-6D06-43A7-86EA-BF0B8C7389FBQ38012612-2F7B7C56-94F4-4530-B80A-3CD665CD1875Q38074607-9CE996F9-8465-439A-8D70-C51DB9B0E618Q38081054-D8731A9C-58F7-49F5-AA70-AC1ED2FD1492Q38166992-F561C038-263C-4883-9B73-328ABB8A2BBEQ38683354-3DC9DC14-0785-42CB-8DE6-FB7F0B4AE22FQ38819049-61C0A388-2055-422D-82A2-849E6AA560D1Q38851916-FF148E93-7603-446F-A14B-D253CC078FF4Q39030372-2DE3F166-3F2B-4DAB-980F-70FFCB91240DQ39275466-230FBC5B-2739-4A83-B788-E6CA34A0BDD7
P2860
The differential effects of EPA and DHA on cardiovascular risk factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The differential effects of EPA and DHA on cardiovascular risk factors.
@en
The differential effects of EPA and DHA on cardiovascular risk factors.
@nl
type
label
The differential effects of EPA and DHA on cardiovascular risk factors.
@en
The differential effects of EPA and DHA on cardiovascular risk factors.
@nl
prefLabel
The differential effects of EPA and DHA on cardiovascular risk factors.
@en
The differential effects of EPA and DHA on cardiovascular risk factors.
@nl
P2093
P2860
P1476
The differential effects of EPA and DHA on cardiovascular risk factors.
@en
P2093
P2860
P304
P356
10.1017/S0029665111000061
P577
2011-02-24T00:00:00Z